PT - JOURNAL ARTICLE AU - Heng Piao AU - Jae Moon Yun AU - Aesun Shin AU - Daehee Kang AU - Belong Cho TI - Comparing non-communicable disease risk factors between Asian migrants and native Koreans: an observational study AID - 10.1101/2020.12.22.20248150 DP - 2021 Jan 01 TA - medRxiv PG - 2020.12.22.20248150 4099 - http://medrxiv.org/content/early/2021/04/16/2020.12.22.20248150.short 4100 - http://medrxiv.org/content/early/2021/04/16/2020.12.22.20248150.full AB - OBJECTIVES To investigate and compare non-communicable disease risk factors among Asian migrants in Korea, the Korean population, and the general population of their respective home countries.DESIGN A cross-sectional (2015) and longitudinal (2009‒2015) observational study.SETTING Population-wide analysis using the National Health Information Database of the Korean National Health Insurance Service for 2009‒2015.PARTICIPANTS Asian migrants (n=987,214) in Korea and Korean nationals (n=1,693,281) aged ≥20 years.MAIN OUTCOME MEASURES The prevalence of non-communicable disease risk factors, such as current smoking, physical inactivity, obesity, diabetes, hypertension, and hypercholesterolemia in 2015. Secondary outcomes were the incidence of type 2 diabetes and hypertension from 2010 to 2015.RESULTS Among participants aged ≥20 years, the age-adjusted prevalence of current smokers was higher among Chinese migrant men (52.8%) than among Korean men (39.9%) (P<0.001) and among other Asian migrant women (6.4%) than among Korean women (3.8%) (P<0.001). The age-adjusted prevalence of obesity was higher in Chinese, Filipino, and other Asian migrant women (25.6%, 30.9% and 35.5%, respectively) than in Korean women (23.2%) (P<0.001; P=0.002; P<0.001, respectively). Among participants aged 20–49 years, the age-adjusted prevalence of diabetes was higher in Filipino migrant women than in Korean women (2.6% and 1.8%, respectively; P=0.009). The age-adjusted prevalence of hypertension was higher in Filipino migrant women than in Korean women (7.7% and 4.2%, respectively; P<0.001). In multivariate analyses, the OR of developing type 2 diabetes was 1.32 (95% CI; 1.11 to 1.57) among Vietnamese migrant men compared with Korean men aged 20–39 years. The ORs of developing hypertension were 1.49 (95% CI; 1.05 to 2.11) and 2.22 (95% CI; 1.17 to 4.19) among Filipino migrant women compared with Korean women aged 20–39 years and more than 40 years, respectively.CONCLUSIONS The identified relationships between Asian migrant nationality and cardiovascular risk factors provide basic evidence for targeting high-risk groups and improving policy development in Korea.WHAT IS ALREADY KNOWN ON THIS TOPICAccording to the healthy migrant effect, international migrants—particularly recent migrants—are healthier than the general population of the host country.Jewish migrants to Israel have health disadvantages compared with Israeli natives.Whether a health advantage exists regarding non-communicable disease risk factors among international migrants, targeting those born in Asian countries and moving to another high-income Asian country such as the Republic of Korea, is unclear.WHAT THIS STUDY ADDSIn 2015, among participants aged ≥20 years, the age-adjusted prevalence of current smokers among Chinese and other Asian migrant men was higher than that among Korean men; the age-adjusted prevalence of obesity among Chinese, Filipino, and other Asian migrant women was higher than that among Korean women.From 2009 to 2015, in multivariate analyses, after adjusting for covariates, among participants aged 20–39 years, Vietnamese migrant men were more likely to have type 2 diabetes than Korean men; among participants aged ≥20 years, Filipino migrant women were more likely to have hypertension than Korean women.The pursuit of better economic, educational, or even social and living environmental needs, combined with the self-selection of migrants as well as the immigration policy of the Korean government may explain the healthy migration advantage concerning diabetes and hypertension among the majority of Asian migrants in Korea.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Seoul National University Hospital (Republic of Korea), Yuhan Pharmaceutical (Republic of Korea), and Henan Cancer Hospital/Affiliated Cancer Hospital of Zhengzhou University (China).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Seoul National University Hospital approved the study on August 21, 2018 (IRB number: E-1808-093-966). Moreover, per IRB's criteria, the need for obtaining informed participant consent was waived in our study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo additional data were available. https://nhiss.nhis.or.kr/bd/ab/bdaba000eng.do;jsessionid=xIoMvELC4gUI0wBh01wHeTUmP1oRqukCUszPBvoRy1JptkJeVJHKa3wGp5s9Jo7h.primrose22_servlet_engine1